Transdermal xenobiotics in newborn skin

Journal of Toxicology - Cutaneous and Ocular Toxicology

Volumn 22, Issue 1-2, 2003, Pages 51-67

  Weinberger, Barry ^a,d   Hanna, Nazeeh ^a   Gropper, Charles A ^b   Heck, Diane E ^c   Laskin, Debra L ^c   Laskin, Jeffrey D ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d SAINT PETER S UNIVERSITY HOSPITAL   (United States)

Author keywords

Infant; Iodine; Latex; Newborn; Skin; Steroids; Topical; Toxicity; Transdermal

Indexed keywords

2 PROPANOL; ANALGESIC AGENT; ANTIINFECTIVE AGENT; CHLORHEXIDINE; CORTICOSTEROID; COTRIMOXAZOLE; EMLA; EMOLLIENT AGENT; IODINE; KATHON CG; LATEX; METHYLXANTHINE; PETROLATUM; PIMECROLIMUS; POVIDONE IODINE; SOLVENT; TACROLIMUS; THEOPHYLLINE DERIVATIVE; TOPICAL AGENT; XENOBIOTIC AGENT; XIPAMIDE;

ALLERGY; ANTISEPSIS; APNEA; CATARACT; CLINICAL TRIAL; CONTACT SENSITIVITY; CUSHING SYNDROME; DRUG SAFETY; ENDOCRINE DISEASE; EPIDERMIS; GROWTH DISORDER; HUMAN; HUMAN TISSUE; HUMIDIFIER; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; METHEMOGLOBINEMIA; NEWBORN; PREMATURITY; RASH; REVIEW; SIDE EFFECT; SKIN ABSORPTION; SKIN ATROPHY; SKIN TOXICITY; STRIA; TELANGIECTASIA; THYROID DISEASE; WEIGHT GAIN;

EID: 0038300364     PISSN: 07313829     EISSN: None     Source Type: Journal    
DOI: 10.1081/CUS-120019330     Document Type: Review

References (109)

1. Eichenfield LF, Hardaway CA. Neonatal dermatology. Curr Opin Pediatr 1999; 11:471-474.
2. West DP, Worobec S, Solomon LM. Pharmacology and toxicology of infant skin. J Investig Dermatol 1981; 76(3):147-150.
3. Harpin VA, Rutter N. Barrier properties of the newborn infant's skin. J Pediatr 1983; 102:419-424.
4. Cunico RL, Maibach HI, Khan H, Bloom E. Skin barrier properties in the newborn: transepidermal water loss and carbon dioxide emission rates. Biol Neonate 1977; 32:177-182.
5. Metry DW, Herbert AA. Topical therapies and medications in the pediatric patient. Pediatr Dermatol 2000; 47(4):867-876.
6. Debton J, Schreiner RL, Pearson J. Circumcision complication - reaction to treatment of local hemorrhage with topical epinephrine in high concentration. Clin Pediatr 1978; 17:285-286.
7. Vivier PM, Lewander WJ, Martin HF, Linakis JG. Isopropyl alcohol intoxication in a neonate through chronic dermal exposure: a complication of a culturally-based umbilical care practice. Pediatr Emerg Care 1994; 10(2):91-93.
8. Siegfried E. Neonatal skin and skin care. Dermatol Clin 1998; 16(3):437-446.
9. Siegfried EC, Shah PY. Skin care practices in the neonatal nursery: a clinical survey. J Perinatol 1999; 19(1):31-39.
10. Cetta F, Lambert GH, Ros SP. Newborn chemical exposure from over-the-counter skin care products. Clin Pediatr 1991; 30(5):286-289.
11. Barrett DA, Rutter N. Percutaneous lignocaine absorption in newborn infants. Arch Dis Child 1994; 71(2):F122-F124.
12. Cartlidge P. The epidermal barrier. Semin Neonatal 2000; 5:273-280.
13. Rutter N. Clinical consequences of an immature barrier. Semin Neonatol 2000; 5:281-287.
14. Mackay PM, Millar MR, Levene MI, Hoy CM, Dealler SF, Papouli M, Ng PC. Development of the transdermal potential of human skin. Pediatr Res 1991; 29(1):78-81.
15. Agren J, Sjors G, Sedin G. Transepidermal water loss in infants born at 24 and 25 weeks of gestation. Acta Pediatr 1998; 87(11):1185-1190.
16. Doty SE, McCormack WD, Sergrave RC. Predicting insensible water loss in premature neonates. Biol Neonate 1994; 66(1):33-44.
17. Kalia Y, Merino V, Guy R. Transdermal drug delivery: clinical aspects. Dermatol Clin 1998; 16(2):289-299.
18. Baker SF, Smith BJ, Donohue PK, Gleason CA. Skin care management practices for premature infants. J Perinatol 1999; 19(6):426-431.
19. Lund CH, Nonato LB, Kuller JM, Franck LS, Cullander C, Durand DJ. Disruption of barrier function in neonatal skin associated with adhesive removal. J Pediatr 1997; 131(3):367-372.
20. Watkins AM, Keogh EJ. Alcohol burns in the neonate. J Paediatr Child Health 1992; 8(4):306-308.
21. McDonald MG, Getson PR, Glascow AM, Miller MK, Boeckx RL, Johnson EL. Propylene glycol: increased incidence of seizures in low birth weight infants. Pediatrics 1987; 79:622-625.
22. Glascow AM, Boeckx RL, Miller MK, MacDonald MG, August GP, Goodman SI. Hyperosmolality in small infants due to propylene glycol. Pediatrics 1983; 72:353-355.
23. Peleg O, Bar-Oz B, Arad I. Coma in premature infant associated with the transdermal absorption of propylene glycol. Acta Paediatr 1998; 87:1195-1196.
24. Kjartansson S, Hammarlund K, Sjors G, Sedin G. Water loss from the skin of term and preterm infants nursed under a radiant heater. Pediatr Res 1995; 37(2):233-238.
25. Kjartansson S, Hammarlund K, Sedin G. Insensible water loss from the skin during phototherapy in term and preterm infants. Acta Paediatr 1992; 81(10):764-768.
26. Maayan-Metzger A, Yosipovitch G, Hadad E, Sirota L. Transepidermal water loss and skin hydration in preterm infants during phototherapy. Am J Perinatol 2001; 18(7):393-396.
27. Strickland ME. Evaluation of bacterial growth with occlusive dressing use on excoriated skin in the premature infant. Neonat Netw 1997; 16(2):29-35.
28. Vernon HJ, Lane AT, Wischerath IJ, Davis JM, Menegus MA. Semipermeable dressing and transepidermal water loss in premature infants. J Pediatr 1990; 86:357-362.
29. Barak M, Hershkowitz S, Rod R, Dror S. The use of a synthetic skin covering as a protective layer in the daily care of low birth weight infants. Eur J Pediatr 1989; 148:665-666.
30. Mancini AJ, Sookdeo-Drost S, Madison KC, Smoller BR, Lane AT. Semipermeable dressings improve epidermal barrier function in premature infants. Pediatr Res 1994; 36:306-314.
31. Ghadially R, Elias P. Effects of petrolatum on stratum corneum structure and function. J Am Acad Dermatol 1992; 26:387.
32. Frosch PL, Lahti A, Hannukscla M. Chloromethylisothiazolone/methylisothiazolone (CMI/MI) use test with a shampoo on patch-test positive subjects. Contact Dermatitis 1994; 32:210-217.
33. Lane AT, Drost SS. Effects of repeated application of emollient cream to premature neonates' skin. Pediatrics 1993; 92(3):415-419.
34. Ziboh VA, Chapkin RS. Biologic significance of polyunsaturated fatty acids in the skin. Arch Dermatol 1987; 123:686a.
35. Schurer NY, Plewig G, Elias PM. Stratum corneum lipid function. Dermatologica 1991; 183:77.
36. Lee EJ, Gibson RA, Simmer K. Transcutaneous application of oil and prevention of essential fatty acid deficiency in preterm infants. Arch Dis Child 1993; 68:27-28.
37. Nopper AP, Horii KA, Sookdeo-Drost S, Wang TH, Mamcini AJ, Lane AT. Topical ointment therapy benefits premature infants. J Pediatr 1996; 128:660-669.
38. Pabst RC, Starr KP, Qaiyumi S, Schwalbe RS, Gewolb IH. The effect of application of aquaphor on skin condition, fluid requirements, and bacterial colonization in very low birth weight infants. J Perinatol 1999; 19(4):278-283.
39. Mitchell IM, Pollock CS, Jamieson PG, Fitzpatrick KC, Logan RW. Transcutaneous iodine absorption in infants undergoing cardiac operation. Ann Thorac Surg 1991; 52:1138-1140.
40. Lyen KR, Finegold D, Orsini R, Herd JE, Parks J. Transient thyroid suppression associated with topically applied povidone-iodine. Am J Dis Child 1982; 136(4):369-370.
41. Pyati SP, Ramamurthy RS, Krauss MT, Plides RS. Absorption of iodine in the cutaneous absorption of iodine. Arch Dis Child 1977; 91:825-828.
42. Chabrolle JP, Rossier A. Goitre and hypothyroidism in the newborn after cutaneous absorption of iodine. Arch Dis Child 1978; 53:495-498.
43. Smerdely P, Lim A, Boyages SC. Topical iodine-containing antiseptics and neonatal hypothyroidism in very-low-birthweight infants. Lancet 1989; 2:661-664.
44. AvRuskin TW, Greenfield E, Prasad V, Fenella G, Juan CS. Decreased T3 and T4 levels following topical application povidone-iodine in premature neonates. J Pediatr Endocrinol 1994; 7(3):205-209.
45. Linder N, Davidovitch N, Reichman B, Kuint J, Lubin D, Meyerovitch J, Sela BA, Dolfin Z, Sack J. Topical iodine-containing antiseptics and subclinical hypothyroidism in preterm infants. J Pediatr 1997; 131(3):434-439.
46. L'Allemand D, Gruters A, Beyer P, Weber B. Iodine in contrast agents and skin disinfectants is the major cause for hypothyroidism in premature infants during intensive care. Horm Res 1987; 28:42-49.
47. Briet JM, van Wassenaer AG, Dekker FW, de Vijlder JJ, van Baar A, Kok JH. Neonatal thyroxine supplementation in very preterm children: developmental outcome evaluated at early school age. Pediatrics 2001; 107(4):712-718.
48. Larsson BA, Jylli L, Lagercrantz H, Olsson GL. Does a local anesthetic cream (EMLA) alleviate pain from heel-lancing in neonates? Acta Anaesthesiol Scand 1995; 39(8):1028-1031.
49. Lindh V, Wiklund U, Hakansson S. Assessment of the effect of EMLA during venipuncture in the newborn by analysis of heart rate variability. Pain 2000; 86(3):247-254.
50. Garcia OC, Reichberg S, Brion LP, Schulman M. Topical anesthesia for line insertion in very low birth weight infants. J Perinatol 1997; 17(6):477-480.
51. Acharya AB, Bustani PC, Phillips JD, Taub NA, Beattie RM. Randomised controlled trial of eutectic mixture of local anaesthetics cream for venipuncture in healthy preterm infants. Arch Dis Child Fetal Neon Ed 1998; 78:F142.
52. Abad F, Diaz-Gomez NM, Domenech E, Gonzalez D, Robayna M, Feria M. Oral sucrose compares favourably with lidocaine-prilocaine cream for pain relief during venipuncture in neonates. Acta Paediatr 2001; 90(2):160-165.
53. Larsson BA, Tannfeldt G, Lagercrantz H, Olsson GL. Alleviation of the pain of venipuncture in neonates. Acta Paediatr 1998; 87(7):774-779.
54. McIntosh N, Van Veen L, Brameyer H. Alleviation of the pain of heel prick in preterm infants. Arch Dis Child Fetal Neonat Ed 1994; 70(3):F177-F181.
55. Stevens B, Johnston C, Taddio A, Jack A, Narciso J, Stremler R, Koren G, Aranda J. Management of pain from heel lance with lidocaine-prilocaine (EMLA) cream: is it safe and efficacious in preterm infants? J Dev Behav Pediatr 1999; 20(4):216-221.
56. Howard CR, Howard FM, Garfunkel LC, de Blieck EA, Weitzman M. Neonatal circumcision and pain relief: current training practices. Pediatrics 1998; 101(3 Pt 1):423-428.
57. Lander J, Brady-Fryer B, Metcalfe JB, Nazareli S, Muttitt S. Comparison of ring block, dorsal penile nerve block, and topical anesthesia for neonatal circumcision: a randomized controlled trial. J Am Med Assoc 1997; 278(24):2157-2162.
58. Arendt-Nielsen L, Bjerring P. Laser-induced pain for evaluation of local analgesia: a comparison of topical application (EMLA) and local injection (lidocaine). Anesth Analg 1998; 67(2):115-123.
59. Taddio A, Stevens B, Craig K, Rastogi P, Ben-David S, Shennan A, Muligan P, Koren G. Efficacy and safety of lidocaine-prilocaine cream for pain during circumcision. N Engl J Med 1997; 336(17):1197-1201.
60. Benini F, Johnston CC, Faucher D, Aranda JV. Topical anesthesia during circumcision in newborn infants. J Am Med Assoc 1993; 270(7):850-853.
61. Taddio A, Ohlsson K, Ohlsson A. http://www.nichd.gov/cochrane/Taddio/Taddiol.ht. - Cochrane Database Syst. Rev. Lidocaine-prilocaine cream for analgesia during circumcision in newborn boys. (Accessed Sept 2002).
62. Joyce BA, Keck JF, Gerkensmeyer J. Evaluation of pain management interventions for neonatal circumcision pain. J Pediatr Health Care 2001; 15(3):105-114.
63. Mohan CG, Risucci DA, Casimir M, Gulrajani-LaCorte M. Comparison of analgesics in ameliorating the pain of circumcision. J Perinatol 1998; 18(1):13-19.
64. Frey B, Kehreer B. Toxic methaemoglobin concentrations in premature infants after application of a prilocaine-containing cream and peridural prilocaine. Eur J Pediatr 1999; 158:785-788.
65. Yaster M, Maxwell LG. Pediatric regional anesthesia. Anesthesiology 1989; 70(2):324-338.
66. Jakobson B, Nilsson A. Methemoglobinemia associated with a prilocainelidocaine cream and trimetoprim-sulphamethoxazole. A case report. Acta Anaesthesiol Scand 1985; 29(4):453-455.
67. Elsner P, Dummer R. Signs of methaemoglobinaemia after topical application of EMLA cream in an infant with haemangioma. Dermatology 1997; 195(2):153-154.
68. Kumar AR, Dunn N, Naqvi M. Methemoglobinemia associated with a prilocainelidocaine cream. Clin Pediatr (Phila) 1997; 36(4):239-240.
69. Couper R. Methaemoglobinaemia secondary to topical lignocaine/prilocaine in a circumcised neonate. J Paediatr Child Health 2000; 36:406-407.
70. Brisman M, Ljung BML, Otterbom I, Larson LE, Andreasson SE. Methaemoglobin formation after the use of EMLA cream in term neonates. Acta Paediatr 1998; 87:1191-1194.
71. Law RM, Halpern S, Martins RF, Reich H, Innanen V, Ohlsson A. Measurement of methemoglobin after EMLA analgesia for newborn circumcision. Biol Neonate 1996; 70(4):213-217.
72. Taddio A, Shennan AT, Stevens B, Leeder JS, Koren G. Safety of lidocaineprilocaine cream in the treatment of preterm neonates. J Pediatr 1995; 127(6):1002-1005.
73. Essink-Tebbes CM, Wuis EW, Liem KD, van Dongen RT, Hekster YA. Safety of lidocaine-prilocaine cream application four times a day in premature neonates: a pilot study. Eur J Pediatr 1999; 158(5):421-423.
74. Lucky AW, Grote GD, Williams JL, Tuley MR, Czemielewski JM, Dolak TM, Herndon JH, Baker MD. Effect of desonide ointment, 0.5%, on the hypothalamic-pituitary-adrenal axis of children with atopic dermatitis. Cutis 1997; 59:151-153.
75. Behrmann RE, Kliegman RM, Arvin AM. Nelson Textbook of Pediatrics. 15th ed. Philadelphia, PA: W.B. Saunders Company, 1996:514.
76. Cassimos C, Kanakoudi-Tsakalidis F, Ladianos M, Tzaphi R. Skin sensitization to 2,4 dinitrochlorobenzene (DNCB) in the first months of life. J Clin Lab Immunol 1980; 3(2):111-113.
77. Custovic A, Murray CS. The effect of allergen exposure in early childhood on the development of atopy. Curr Allergy Asthma Rep 2002; 2(5):417-423.
78. Bjorksten F, Suoniemi I, Koski V. Neonatal birch-pollen contact and subsequent allergy to birch pollen. Clin Allergy 1980; 10(5):585-591.
79. Kihlstrom A, Lilja G, Pershagen G, Hedlin G. Exposure to birch pollen in infancy and development of atopic disease in childhood. J Allergy Clin Immunol 2002; 110(1):78-84.
80. Carey AB, Cornish K, Schrank P, Ward B, Simon R. Cross-reactivity of alternate plant sources of latex in subjects with systemic IgE-mediated sensitivity to Hevea brasiliensis latex. Ann Allergy Asthma Immunol 1995; 74:317-320.
81. Worth J. Neonatal sensitization to latex. Med Hypotheses 2000; 54:729-733.
82. Theissen U, Theissen JL, Mertes N, Brehler R. IgE-mediated hypersensitivity to latex in childhood. Allergy 1997; 52:665-669.
83. Ricci G, Gentili A, DiLorenzo F, Righetti F, Pigna A, Masi M. Latex allergy in subjects who had undergone multiple surgical procedures for bladder extrophy: relationship with clinical intervention and atopic diseases. BJU Int 1999; 84:1058-1062.
84. DeMichael T, Niggemann B, Moers A, Seidel U, Wahn U, Scheffner D. Risk factors for latex allergy in patients with spina bifida. Clin Exp Allergy 1996; 26:934-939.
85. Drexler S, Strehl E, Heese A, Wenzel D, Stehr K. Prevalence and risk factors of type I latex allergy in children with spina bifida. Monatsschr Kinderheilkd 1995; 143:998-1002.
86. Novembre E, Bernardini R, Brizzi I, Bertini G, Mugnaini L, Azzari C. The prevalence of latex allergy in children seen in a university hospital allergy clinic. Allergy 1997; 52:101-105.
87. Ylitalo L, Turjanmaa K, Palosuo T, Reunala T. Natural rubber latex allergy in children who had not undergone surgery and children who had undergone multiple operations. J Allergy Clin Immunol 1997; 100:606-612.
88. American Academy of Allergy, Asthma & Immunology. http://www.aaaai.org - Tips To Remember - Latex Allergy (accessed Sept 2002).
89. Levy DA, Charpin D, Pecquet C, Leynadier F, Vervloet D. Allergy to latex. Allergy 1992; 47:579-587.
90. Sussman GL, Tarlo S, Dolovich J. The spectrum of IgE-mediated responses to latex. J Am Med Assoc 1991; 265:2844-2847.
91. Anthony H, Birtwhistle S, Eaton K, Maberley J. Environmental Medicine in Clinical Practice. Southampton: BSAENM Publications, 1997:335.
92. Barnes PJ, Grunstein MM, Leff RR, Woolcock AJ. Asthma. Vol. II. New York: Lippincott-Raven, 1997:1407.
93. Zucker-Pinchoff B, Stadtmauer GJ. Latex allergy. Mt Sinai J Med 2002; 69(1-2):88-95.
94. Slater JE. Latex allergy. J Allergy Clin Immunol 1994; 94:139-149.
95. Beezhold D, Beck WC. Surgical glove powders bind latex antigens. Arch Surg 1992; 127:1354-1357.
96. Newson SWB, Shaw M. A survey of starch particle counts in the hospital environment in relation to the use of powdered latex gloves. Occup Med 1997; 47:155-158.
97. Baur X. Allergic reactions to airborne latex allergens. Allergologie 1995; 18:568-571.
98. Beck LA, Leung DYM. Allergen sensitization through the skin induces systemic allergic responses. J Allergy Clin Immunol 2000; 106:S258-S263.
99. Cremer R, Hoppe A, Kleine DU, Blaker F. Effects of prophylaxis on latex sensitization in children with spina bifida. Eur J Pediatr Surg 1998; 8(suppl 1):59.
100. AAAAI and ACAAI joint statement concerning the use of powdered and non-powdered natural rubber latex gloves. Ann Allergy Asthma Immunol 1997; 79:487.
101. Brehler R, Kutting B. Natural rubber latex allergy: a problem of interdisciplinary concern in medicine. Arch Intern Med 2001; 161(8):1057-1064.
102. Barrett DA, Rutter N, Davis SS. An in vitro study of diamorphine permeation through premature human neonatal skin. Pharm Res 1993; 10(4):583-587.
103. Nachman RL, Esterley NB. Increased skin permeability in preterm infants. J Pediatr 1971; 79:628-632.
104. Wilson DR, Maibach H. Transepidermal water loss in vivo in premature and term infants. Biol Neonate 1980; 37:180-185.
105. Amato M, Isenschmid M, Huppi P. Percutaneous caffeine application in the treatment of neonatal apnoea. Eur J Pediatr 1991; 150:592-594.
106. Amato M, Huppi P, Isenschmid M, Schneider H. Developmental aspects of percutaneous caffeine absorption in premature infants. Am J Perinatol 1992; 9(5-6):431-434.
107. Micali G, Bhatt RH, Distefano G, Caltabiano L, Cook B, Fischer JH, Solomon LM, West DP. Evaluation of transdermal theophylline pharmacokinetics in neonates. Pharmacotherapy 1993; 13(4):386-390.
108. Cartwright RG, Cartlidge PHT, Rutter N, Melia CD, Davis SS. Transdermal delivery of theophylline to premature infants using a hydrogel disc system. Br J Clin Pharmacol 1990; 29:533-539.
109. Murphy MG, Peck CC, Conner DP, Zamani K, Merenstein GB, Rodden D. Transdermal theophylline collection in premature infants. Clin Pharmacol Ther 1990; 47(4):427-434.